Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news Horizon Bank partners with Blend to transform mortgage lending Horizon Bank, a prominent $8 billion financial institution and division of Horizon Bancorp, Inc. (NASDAQ GS: HBNC), has… byPallavi MadhirajuJuly 26, 2024